Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Genus Pharmaceuticals
Park View House, 65 London Road, Newbury, Berkshire, RG14 1JN
Telephone: +44 (0)1635 568 400
Fax: +44 (0)1635 568 401
Medical Information Direct Line: +44 (0)870 851 0207
Medical Information e-mail: genus@medinformation.co.uk
Customer Care direct line: +44 (0)1635 568 445
Medical Information Fax: +44 (0)1793 710 387

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/02/2012
PIL APO-go AMPOULES 10mg/ml Solution for Injection or Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Number
  • Change to manufacturer contact details
Updated on 25/08/2010 and displayed until 21/02/2012
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to how the medicine works
  • Change to storage instructions
  • Change to side-effects
  • Introduction of new pack/pack size
Updated on 09/03/2010 and displayed until 25/08/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 29/01/2010 and displayed until 09/03/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Addition of Marketing Authorisation Holder
Updated on 18/01/2010 and displayed until 29/01/2010
Reasons for adding or updating:
  • Change of manufacturer
Updated on 18/09/2009 and displayed until 18/01/2010
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to warnings or special precautions for use
Updated on 25/08/2009 and displayed until 18/09/2009
Reasons for adding or updating:
  • Removal/change of distributor
Updated on 24/11/2008 and displayed until 25/08/2009
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 15/07/2008 and displayed until 24/11/2008
Reasons for adding or updating:
  • Change of manufacturer
Updated on 23/07/2007 and displayed until 15/07/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/07/2007 and displayed until 23/07/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/09/2006 and displayed until 13/07/2007
Reasons for adding or updating:
  • Change of manufacturer
Updated on 01/06/2006 and displayed until 22/09/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 22/05/2006 and displayed until 01/06/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 13/04/2005 and displayed until 22/05/2006
Reasons for adding or updating:
  • Change of manufacturer
  • Change to appearance of the medicine
Updated on 28/09/2004 and displayed until 13/04/2005
Reasons for adding or updating:
  • Change of manufacturer
  • Change to how to administer the medicine
Updated on 11/06/2003 and displayed until 28/09/2004
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • Update to PIL
Updated on 20/04/2001 and displayed until 11/06/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  apomorphine hydrochloride